ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 243 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,000 | – | 2 | – | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 13 | +8.3% | 0.00% | – |
| Q4 2020 | $1,000 | – | 12 | +9.1% | 0.00% | – |
| Q3 2020 | $0 | – | 11 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | – | 0 | – | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q1 2019 | $22,000 | +83.3% | 500 | +63.9% | 0.00% | +200.0% |
| Q4 2018 | $12,000 | – | 305 | +6000.0% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 5 | -85.7% | 0.00% | – |
| Q2 2018 | $2,000 | +100.0% | 35 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | -75.0% | 35 | -75.0% | 0.00% | – |
| Q3 2017 | $4,000 | +100.0% | 140 | 0.0% | 0.00% | – |
| Q2 2017 | $2,000 | -90.9% | 140 | -72.0% | 0.00% | -100.0% |
| Q1 2016 | $22,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 4,190,000 | $321,918,000 | 5.54% |
| Prosight Management, LP | 145,700 | $11,194,000 | 5.17% |
| Integral Health Asset Management, LLC | 200,000 | $15,366,000 | 4.57% |
| Copernicus Capital Management, LLC | 3,740 | $287,000 | 4.47% |
| GREAT POINT PARTNERS LLC | 345,120 | $26,516,000 | 4.31% |
| Asymmetry Capital Management, L.P. | 101,245 | $7,779,000 | 3.55% |
| First Light Asset Management, LLC | 321,967 | $24,737,000 | 1.83% |
| DAFNA Capital Management LLC | 76,815 | $5,902,000 | 1.76% |
| SECTORAL ASSET MANAGEMENT INC | 320,059 | $24,590,000 | 1.73% |
| Nicholas Investment Partners, LP | 276,633 | $21,254,000 | 1.64% |